We are live on ! Find out more
CG

Cutler Group Portfolio holdings

AUM $307M
1-Year Est. Return 45.11%
This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.49%
10 Year Est. Return
AUM
$1.44B
AUM Growth
+$188M
Cap. Flow
+$1.09B
Cap. Flow %
75.9%
Top 10 Hldgs %
19.6%
Holding
5,165
New
988
Increased
1,455
Reduced
1,368
Closed
1,084

Sector Composition

Rank Sector Weight
1 Communication Services 12.86%
2 Technology 10.77%
3 Consumer Discretionary 8.91%
4 Financials 4.75%
5 Energy 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ICPT
701
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$273K 0.02%
8,400
+5,200
+163% +$550K
SOHU
702
PUT
Sohu.com
SOHU
$336M
$272K 0.02%
+28,800
New +$731K
TNDM icon
703
CALL
Tandem Diabetes Care
TNDM
$1.17B
$272K 0.02%
54,100
+41,700
+336% +$1.46M
NEM icon
704
PUT
Newmont
NEM
$98.2B
$271K 0.02%
142,600
+91,000
+176% +$3.08M
AMD icon
705
PUT
Advanced Micro Devices
AMD
$851B
$270K 0.02%
237,900
+181,600
+323% +$4.1M
KRE icon
706
CALL
State Street SPDR S&P Regional Banking ETF
KRE
$4.86B
$270K 0.02%
107,100
-65,100
-38% -$4.06M
TFCFA
707
PUT
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$270K 0.02%
280,100
-15,900
-5% -$729K
CLR
708
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$268K 0.02%
3,926
-14,970
-79% -$945K
MRVL icon
709
Marvell Technology
MRVL
$174B
$267K 0.02%
13,841
+13,814
+51,163% +$284K
PTLA
710
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$267K 0.02%
21,200
+2,500
+13% +$81.6K
UFS
711
DELISTED
DOMTAR CORPORATION (New)
UFS
$267K 0.02%
5,122
-19,004
-79% -$957K
HBI
712
DELISTED
Hanesbrands
HBI
$266K 0.02%
14,467
-5,395
-27% -$105K
JNJ icon
713
CALL
Johnson & Johnson
JNJ
$635B
$266K 0.02%
42,500
-1,000
-2% -$133K
NKTR icon
714
CALL
Nektar Therapeutics
NKTR
$2.39B
$266K 0.02%
1,133
-814
-42% -$695K
URI icon
715
CALL
United Rentals
URI
$71.1B
$266K 0.02%
9,800
+3,000
+44% +$467K
LNW
716
PUT
DELISTED
Light & Wonder
LNW
$265K 0.02%
26,900
+11,500
+75% +$417K
NKTR icon
717
Nektar Therapeutics
NKTR
$2.39B
$261K 0.02%
286
-533
-65% -$455K
UNH icon
718
UnitedHealth
UNH
$382B
$261K 0.02%
982
+926
+1,654% +$241K
PARA
719
DELISTED
Paramount Global Class B
PARA
$260K 0.02%
4,539
-8,806
-66% -$486K
PNC icon
720
PNC Financial Services
PNC
$100B
$260K 0.02%
1,910
+1,837
+2,516% +$261K
GWRE icon
721
Guidewire Software
GWRE
$11.5B
$256K 0.02%
2,539
+1,176
+86% +$113K
LOXO
722
DELISTED
Loxo Oncology, Inc
LOXO
$256K 0.02%
1,500
+600
+67% +$101K
AVNS icon
723
Avanos Medical
AVNS
$1.17B
$255K 0.02%
+3,725
New +$240K
SWN
724
DELISTED
Southwestern Energy Company
SWN
$255K 0.02%
50,000
-12,343
-20% -$65.4K
P
725
Everpure Inc
P
$24.8B
$254K 0.02%
9,816
-10,446
-52% -$260K

Similar funds

Cutler Group's Q3 2018 Portfolio in Review

As of Q3 2018, Cutler Group held 5,165 positions worth $1.44B, up 15% from $1.25B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cutler Group deployed $1.09B of net new capital in Q3 2018, opening 988 new positions and adding to 1,455 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 37,396 shares worth $13.7M.

By sector, the portfolio is most concentrated in Communication Services at 13% of assets, up from 9.8% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $28.2M trimmed.

  • Cutler Group's largest Q3 2018 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 37,396 shares worth $13.7M.
  • Cutler Group added most to Invesco QQQ Trust in Q3 2018, an estimated $49.9M increase.
  • Cutler Group's biggest Q3 2018 reduction was Apple, cutting an estimated $28.2M.
  • Cutler Group fully exited State Street SPDR S&P Biotech ETF in Q3 2018, selling an estimated $10M.
  • Cutler Group's ten largest holdings make up 20% of its $1.44B portfolio in Q3 2018.
  • Cutler Group opened 988 new positions and closed 1,084 in Q3 2018.
  • Cutler Group's portfolio value rose 15% quarter-over-quarter to $1.44B.

Based on Cutler Group's 13F filing for Q3 2018, filed 7 Nov 2018.